Juvenil Idiopatic Arthritis research hub

Treatment strategies for juvenile idiopathic arthritis patients with sustained inactive disease: A phase 4, multicentre, randomised trial comparing maintenance versus tapered TNF alpha inhibitor monotherapy - the Treat-JIA trial

This study looks at young people with juvenile idiopathic arthritis whose condition is currently quiet and well controlled. Researchers want to find out whether it is safe to slowly reduce and stop their regular biologic injections, or if it is better to carry on taking them as normal.